Download Annual Report - Boston Foundation for Sight

Vision Restored. Lives Reclaimed.
A N N U A L
R E P O R T
2 0 1 4
Bringing Patients Back Into the Light
As Boston Foundation for Sight moves into its third decade, we are proud that
awareness and acceptance of BostonSight® PROSE treatment continues to build.
This has been fostered by the success of our provider network and a rapidly
growing body of peer-reviewed publications that attest to the value of PROSE for
treatment of complex corneal disease.
PROSE treatment is successful in 95 percent of those who receive it. For so many
patients, it offers a way back into the light. We are gratified by the knowledge that
our leadership and—dare we say it—vision have created a vibrant community of
ophthalmologists and optometrists who treat patients around the world.
Moreover, we continue to invest resources in a number of areas to restore
vision and help our patients reclaim their lives. First, we are committed to
offering financial aid to those who need it—patients who will otherwise be denied
PROSE treatment. Also, we must continue to provide education and training to
ophthalmologists and optometrists, while conveying to patients—and their
families—that they can live full lives despite their difficult diagnoses. Finally,
we aim to advance innovation in the design, customization and overall approach
to PROSE treatment.
With the goal of growing BFS responsibly, we have developed five funding
priorities, which are featured in this Annual Report. These priorities reflect a
commitment by our team at Boston Foundation for Sight—talented people who
provide the compassionate care that is the hallmark of BFS. People make the
difference here. That includes our great patients who support and nurture each
other, and donate generously to help others gain access to PROSE treatment.
Boston Foundation for Sight cannot meet the major challenges we face without
your support. Vision is precious; it is the sense that we value most. With your help,
we can provide a greater number of individuals with a way back into the light.
Sincerely,
Eugene A. Bonte
President and CEO
Gary A. Knaak
Chairman, Board of Directors
Fundraising Goal:
Enhancing Our Medical
Education and Training
Programs
Expanding and
Supporting the
BostonSight® Network
Key Accomplishments for 2014
•
•
•
•
•
•
•
Boston Foundation for Sight provided more than $634,110 in financial assistance to 168
patients at the Needham, Massachusetts center and an additional $97,500 in assistance
to patients within the U.S. provider network.
More than 1,175 patients worldwide received BostonSight® PROSE treatment.
The Boston Foundation for Sight lab manufactured a total of 9,500 devices
in support of PROSE treatment.
The University of Rochester Flaum Eye Institute joined the BostonSight® Network.
Boston Foundation for Sight held its second BostonSight® PROSE User Group
meeting at the American Academy of Ophthalmology annual meeting.
Boston Foundation for Sight continued its tradition of welcoming adults and
children with Stevens Johnson syndrome to the fifth annual SJS Care Week.
Over the last 25 years, 41 peer-reviewed publications have attested to the impact
of PROSE treatment. Twenty-one of those were published in the last five years—
triple the number from the previous five years.
PAGE 1
Steve Corlett (left),
director of lab operations,
and Manoel Carvalho,
lab manager, assure the
highest quality in the
manufacture of
PROSE devices.
Out of Severe Eye Pain and Busy Again
New Hampshire Resident Is No Longer
Defined by Her Eye Problem
Each life has hurdles to be faced and endured. Karen-Lee
Simpson has faced numerous, life-threatening hurdles—
notably, multiple serious diagnoses that dominated her
life for more than a decade. Ms. Simpson survived
chronic myelogenous leukemia, years of chemotherapy, a
stem cell transplant and a long list of other medical
problems and complications. On top of these issues, she
faced constant pain due to her severely dry eyes.
“The pain began in 2004, a few years after my stem cell
transplant, and it was debilitating,” says the Nashua,
New Hampshire, resident. “Most nights I woke out of a
sound sleep because the pain in my eyes was too much to
bear. I had to put drops in my eyes every 15 minutes.”
Ms. Simpson’s life also was limited by diminishing vision,
so that she could no longer sing in her church choir and
was barely able to drive. “There were aging relatives I
hadn’t seen in years and who I missed so much,” she says.
“But I couldn’t get to them. I depended on other people
to drive me where I needed to go, including Dana-Farber
Cancer Center for treatment.”
One day while sitting in a waiting room at Dana-Farber
and placing drops in her burning, painful eyes, she
received the answer to her long-standing problem.
“A man sitting across from me said ‘I have something to
show you,’” she recalls. “He removed a PROSE device
from his eye, mentioned Boston Foundation for Sight,
handed me Dr. Jacobs’s business card and said ‘they’ll
help you.’”
Despite the roadblock of first needing cataract surgery,
Ms. Simpson was soon in an exam room with Deborah S.
Jacobs, MD, BFS medical director, who inserted a pair of
trial PROSE devices and encouraged her to spend some
time walking around.
“I had such clarity of vision that I realized I had been
virtually blind,” says Ms. Simpson. “Within 20 minutes,
all the pain was gone. It was amazing; I was overjoyed.”
BFS provides funds to pay for treatment
Her initial introduction to PROSE treatment was
followed by the customization process, which was
performed by Alan Kwok, OD. He has treated many
patients who suffer from extremely dry eyes. “Whether
someone has ocular graft-vs-host disease due to a stem
cell tranplant or severe dry eye caused by other medical
conditions, when the lacrimal gland no longer produces
tears, the eye becomes light-sensitive, extremely irritated
and red—like a war zone,” Dr. Kwok explains. “Artificial
tears will help, but for less than five minutes. As soon as
someone begins wearing PROSE devices, the eyes quiet
down because the environment over the corneas is how it
should be.”
Indeed, Ms. Simpson’s eyes responded quickly, and—
motivated to return to a full life—she learned to apply
and remove her PROSE devices in no time. “Before going
to Boston Foundation for Sight, I went on YouTube and
watched their training videos so that I would be ready for
life with PROSE devices,” she says.
There was another important detail: Ms. Simpson’s
health insurance would not cover the cost of her PROSE
treatment. However, BFS covered more than half the total
cost. One of the organization’s top funding priorities is
raising additional funds to cover the cost of PROSE
treatment for those who will otherwise be unable to
receive it. Those days at BFS had an impact on Ms.
Simpson. “I met people from all over the world and from
all walks of life who found BFS through word of mouth
or a prayer,” she says. “I began to realize how much pain
I had been in—for nine years—and how much energy it
took to live my life.”
Another hurdle to climb
Back home again, Ms. Simpson prepared to drive to her
daughter’s home for Thanksgiving. “I hadn’t been able to
drive on the highway in years,” she says. After she arrived
that evening, Ms. Simpson suffered an accident that seems
incomprehensible: she tripped on the hem of her nightgown
as she headed down the stairs, fell and broke her hand and
wrist, bruised ribs and tore both rotator cuffs.
PAGE 2
“I’m busy again and loving it,”
says Karen-Lee Simpson of
Nashua, New Hampshire, who
now enjoys making jewelry
thanks to PROSE treatment.
Funding Goal #1:
Providing Financial
Assistance to
Those Who Need
Treatment
“I was lucky to be alive, but I cried for two weeks,” she
says. During her rehabilitation, which stretched to more
than a year, Ms. Simpson was unable to insert or remove
her PROSE devices. “The people at Boston Foundation
for Sight suggested I put them in dry dock until my hand
worked again.” By March 2014, Ms. Simpson was back to
wearing her devices and is more grateful than ever.
“I’m busy again and loving it,” she says, noting that her
life is full—with providing counseling services, making
jewelry, working out and participating in a TV program
that is in development. “The theme is people who have
overcome adversity.”
Ms. Simpson knows a lot of about that. Being diagnosed
with leukemia and getting through a long, difficult
treatment regimen was tough enough. “Along the way,
I suffered a stroke, had several surgeries, developed
diabetes, was diagnosed with kidney cancer, had
double-pneumonia twice and was in a coma for ten days,”
she says. “While I was battling the leukemia and
everything else, my eyes came second.”
This is a familiar scenario at BFS, says Dr. Kwok.
“When patients have battled for their lives due to cancer,
as Ms. Simpson did, they learn to cope with their other
problems,” he observes. “They’ve been through so much;
they tend to handle the challenge of their serious
eye pain.”
“For more than nine years, my eye problem defined
me as a person,” says Ms. Simpson. “But no more. Now,
whenever I get the opportunity to tell someone about
Boston Foundation for Sight, I pass it on.”
PAGE 3
The Patient and Family Support Center
The Kitchen: The Heart and Soul of BFS
Funding Goal #2:
Growing Our
Patient and
Family Fund
“We usually suggest that patients spend
time in the center during their PROSE
device wearing assessments,” says Karen
Carrasquillo, OD, PhD, director of
clinical care. “While they are there,
People stop in for coffee, a snack or a
patients often meet someone who is
meal, but they also go there to relax and already benefitting from PROSE
reflect. For many, it is where they
treatment, and they become hopeful, too.
realize that PROSE treatment is going
to provide a way back into the light.
“For patients with similar conditions,
The Patient and Family Support
the kitchen becomes a forum for
Center—also known as “the kitchen”— conversation,” she notes. “They develop
is the heart and soul of Boston
a sense of belonging.”
Foundation for Sight.
That is especially true each summer,
“It is the first place I stop on my visits
when SJS Care Week is held at Boston
to BFS,” notes Gary Knaak, BFS board
Foundation for Sight, and patients
chair, who is also a patient.
with Stevens Johnson syndrome (SJS)—
children and adults alike—fill the room.
It’s not a waiting room. It is a community
gathering place where long-standing
friendships begin and experiences
are shared.
PAGE 4
The Patient and Family
Support Center often serves
as a forum for conversation
where long-lasting
friendships begin.
“Everyone gathers around the table,
and we catch up the way a family
does,” says Mariam Khawam, who
travels from Chicago to attend the
annual event at BFS. “It’s like a
reunion, but you meet new people.”
Ms. Khawam also knows the kitchen
as a quiet place, which is what she
needed when she first came to BFS,
accompanied by her mother and
brother, in 2011. A college freshman at
the time, she had been diagnosed with
toxic epidermal necrolysis (TENS), a
variant of SJS, and had almost given up
hope for regaining her vision.
“When I first had PROSE devices
inserted, I started crying because I saw
my mother’s face for the first time in
two years,” she recalls.
Later on, in the kitchen, Ms. Khawam
began to relax. “That’s where the
healing started,” she says. “Pretty soon
I was talking with other patients—
people from around the world who
had diagnoses I’d never heard of.
We learn so much from each other,
mostly how our eye problems left us
emotionally drained.”
PAGE 5
The Patient and Family Support
Center is stocked with food and
beverages and becomes an oasis for
individuals who come to Boston
Foundation for Sight to get their lives
back. In the kitchen, patients reflect on
their experience, make friends and
are less alone.
That is the point, says Dr. Carrasquillo.
“The center originally was established
because so many patients come to
Boston Foundation for Sight from
outside the region. They needed a
place to spend time. It has evolved to
become so much more than that. So
many long-lasting friendships have
started there.”
NETWORK EXPANSION BENEFITS MANY
Talented PROSE Doctors Head Off to New York and Texas
The dual goals of expanding the BostonSight® Network and providing clinical
education on PROSE treatment are closely linked. A steady stream of talented cornea
fellows and optometry residents comes to Boston Foundation for Sight to learn about
In addition to the presence of
outstanding cornea specialists,
the treatment of complex corneal disease and the benefits of PROSE treatment.
Flaum Eye Institute is the site of
Future PROSE providers from around the country also come to BFS for intensive
research that may expand
training as PROSE clinical fellows.
the application and use of
The most recent PROSE clinical fellow, Major Kelly Olson, OD, MBA, was selected to
undertake the nine-week training when Lieutenant Colonel Evelyn Reyes-Cabrera,
OD, who had served as the PROSE provider at Brooke Army Medical Center (BAMC)
in San Antonio, Texas, was reassigned. Dr. Olson is director of optometry education
programs at BAMC and now spends about half his time seeing PROSE patients (see
page 8).
PROSE treatment.
The BostonSight® Network added a twelfth U.S. site—the third in New York—when
Flaum Eye Institute became a PROSE provider in late 2014. The story of how the
respected eye institute, which is located at the University of Rochester Medical
Center, joined the BostonSight® Network is unique. In addition to the presence of
outstanding cornea specialists, Flaum Eye Institute is the site of research that may
expand the application and use of PROSE treatment (see page 10). Moreover, a
grateful and generous patient who received PROSE treatment in 2008 made a gift to
underwrite the startup costs associated with Flaum joining the network.
“This was the first time that research was part of the motivation to launch a new site,”
notes Ilene Knopping, director of the BostonSight® Network. “Dr. Yoon has been
investigating the potential for expanding the capabilities of PROSE treatment to
improve vision in patients with higher order aberrations [HOA].” In the past,
Geunyoung Yoon, PhD, director of the Yoon Lab at Flaum, has traveled to BFS to
conduct clinical research on patients whose vision is limited by HOAs, complex
deviations from normal vision that often occur in those with keratoconus. Dr. Yoon
has developed innovative ways to measure these aberrations and, in an ongoing
collaboration with BFS, found ways to incorporate HOA corrections into PROSE devices.
James Aquavella, MD, a cornea specialist at Flaum, has been eager to offer PROSE
treatment at the busy, diverse institute. “I see patients with complex corneal disease
and have referred them to Boston Foundation for Sight,” says Dr. Aquavella. “I know
that PROSE treatment is a great benefit to them; it’s been my goal for several years to
incorporate PROSE here at Flaum.”
PAGE 6
Funding Goal #3:
Expanding and
Supporting the
BostonSight® Network
A grateful PROSE patient makes a generous gift
Flaum Eye Institute (FEI) now has a
The chorus of support for Flaum to join the BostonSight® Network included Joseph
Hanna, one of Dr. Aquavella’s patients. “Joe has a unique form of ocular surface
disease,” he explains, noting that he tried several different treatments to address Mr.
Hanna’s painful dry eyes, to no avail. “In 2008, we sent him to Boston Foundation for
Sight so that he could receive PROSE treatment.”
PROSE treatment exam room, thanks to a
generous gift from Joseph and Linda Hanna.
Gathering to see the new room are
(left to right) Tara Vaz, OD,
Steven Feldon, MD, FEI director,
“My vision was fine,” Mr. Hanna explains. “By healing the ocular surface, PROSE had
Mr. Hanna, James Aquavella, MD, and
an impact on my quality of life; the treatment was very effective. In fact, the entire
Geunyoung Yoon, PhD.
experience at Boston Foundation for Sight was positive. The staff is so dedicated, and
they were very good to me.”
Before long, Mr. Hanna—a member of the Flaum Eye Institute Board of Trustees—was
involved in discussions about Flaum joining the BostonSight® Network. “I saw what
PROSE treatment did for me,” Mr. Hanna says. “I have friends with eye problems, and
their lives are diminished as a result.” He, Dr. Aquavella and Dr. Yoon all lobbied to
bring PROSE treatment to Flaum.
Soon Mr. Hanna, who has made gifts to BFS, as well as Flaum—to support Dr.
Aquavella’s lab and the ongoing ocular surface research—offered to underwrite the
costs associated with launching a PROSE site, which allowed the institute to move
forward. The first step was for Dr. Aquavella to recruit an optometrist who was
enthusiastic about providing PROSE treatment. He succeeded in recruiting Tara Vaz,
OD, who brought an outstanding background that includes research.
PAGE 7
“By healing the ocular surface,
PROSE had an impact on my
quality of life; the treatment was
very effective.”
—Joseph Hanna
Funding Goal #4:
Enhancing Our
Medical Education
and Training Programs
“I knew of PROSE treatment and have always been interested in it,” says Dr. Vaz. “I
was eager to expand my depth of knowledge, and the research component at Flaum
Eye Institute attracted me.”
Training at BFS: invigorating, challenging and inspiring
Dr. Vaz was impressed with everything she observed during her nine-week intensive
training at BFS. “I was struck by how everyone works in tandem,” she says. “The
turnaround in the lab’s ability to manufacture PROSE devices is phenomenal. It was
an invigorating and challenging experience for me; I had to be on my toes at all times
while I was at BFS. I learned so much.”
Like all PROSE providers, Dr. Vaz has patients she won’t forget. “During my training, I
treated a patient who suffered from Stevens Johnson syndrome and had persistent
epithelial defect,” she says. “Multiple treatments had failed. But PROSE treatment
worked, and she was so thankful.”
When Dr. Vaz returned to Flaum Eye Institute, she began following existing PROSE
patients, as well as consulting on cornea clinic patients who are candidates for the
treatment. “In the early months, there were situations where I needed assistance with
customizing devices and obtaining insurance coverage for patients,” she says. “They
are so supportive. I have everyone’s direct line at Boston Foundation for Sight.”
Dr. Vaz says she is eager to help spread the word about PROSE. “Too many cornea
specialists—ophthalmologists and optometrists—don’t know what PROSE offers
patients,” she says. “I have found out how rewarding it is to provide this treatment.”
A lot happened at Flaum Eye Institute in 2014 thanks to the decision to join the
BostonSight® Network. Promising research is being supported, new research is being
planned, and individuals living in the Rochester area who need PROSE treatment can
turn to their trusted and prestigious local eye institute. “I’m pleased that my gift has
had an impact on the quality of life of other people,” says Mr. Hanna, who continues
to be impressed with the BFS staff. “Ilene Knopping does an excellent job in
coordinating the support at network sites.
“People are benefiting from having PROSE treatment available in Rochester, and that
makes me happy.”
PAGE 8
A Unique Mission
at Brooke Army
Medical Center
Major Kelly Olson, OD, MBA,
Saw Miracles Happen
at BFS
At Brooke Army Medical Center,
Major Kelly Olson, OD, MBA,
and his colleagues see a diverse
population of patients—not only
current and retired soldiers, but
also their spouses and children.
“We have the unique mission of
supporting war fighters by
making sure they are ready to go
to war and into harm’s way,” says
Dr. Olson.
A certain number of them, such
as soldiers who have suffered
facial/ocular burns, are candidates
for PROSE treatment. After nine
weeks of training at BFS, Dr. Olson
is prepared to provide it. “The
doctors at Boston Foundation
for Sight who trained me were
excellent,” he says. “I was
impressed with the precision
used to produce PROSE devices
and, from the time I arrived at
BFS, surprised at the frequency
“When I was at BFS,
I called my family
every night, and
my kids would say to
me ‘Dad, who did
you help today?’”
—Major Kelly Olson, OD, MBA
of severe cases they see there. I
received a tremendous education
through my observation and
interaction with these patients.”
Dr. Olson says he felt a bit spoiled by
the first patient he treated. “She was
a sweet woman from Vermont who
had been struggling for a long time
with dry eyes,” he recalls. “We put the
PROSE devices in her eyes, and she
was completely overwhelmed by the
improved vision and reduction in
her pain.
“She started crying, and there were
hugs all round. For me, it set the stage
for the kinds of miracles that occur
at BFS. When I was there, I called my
family every night, and my kids would
say to me ‘Dad, who did you help
today?’ Providing PROSE treatment is
among the greatest things I’ve done in
my career.”
As a military optometrist, Dr. Olson
has traveled throughout the country
and the world, including to Iraq, where
he was based at Camp Anaconda
during 2005-2006. The base camp,
located 40 miles north of Baghdad,
was one of the largest U.S. military bases
during the war.
Working with a local dentist who made
teeth, Dr. Olson created prosthetic eyes
for 24 children. “Needless to say, in
addition to improving the quality of life
of those kids, this became a source of
goodwill with the local sheikhs and tribal
leaders in the area, who brought their
children to us,” Dr. Olson recalls. “I made
24 friends in Iraq.”
Leaving base camp put Dr. Olson at risk
for being mortared or bombed. “In
Ramadi, I saw soldiers come in with
catastrophic injuries and did would I
could to help, even if it was just donating
blood,” he says. “You develop respect
and reverence for those soldiers who
sacrifice their lives.”
He also made plenty of friends during
his training at BFS. “I consider everyone
at BFS to be my friends, as well as my
colleagues,” he says. “I know that if
I need their help with a clinical
problem, they’ll be there to solve it.
Mostly, I will never forget the
compassion they have for their patients.”
Making friends in Iraq
Dr. Olson found an unexpected role
to play while in Iraq. “I was aware of
children who had lost an eye,” he says.
“I took an elective course on fabricating
prosthetic eyes when I was in optometry
school, never knowing if I would ever use
that skill.”
PAGE 9
RESEARCH ON PROSE IS INCREASINGLY DIVERSE
Many Studies Are Performed at
BostonSight® Network Clinics
As more people continue to benefit
from PROSE treatment, the amount of
research devoted to PROSE has steadily
increased. Past research provided clear
evidence of the treatment’s impact on
those with complex corneal diseases.
Current research, including investigations
underway during 2014, aims to expand the
use of PROSE treatment to benefit more
individuals and to make the customization
of PROSE devices a quicker, more efficient
process, which will reduce the number of
visits patients are required to make.
Publishing research is a good way to
increase awareness and acceptance of
PROSE treatment—an important focus for
Deborah S. Jacobs, MD, from the time she
arrived as medical director in 2006. “In
2007, two different studies were published on patients with ocular graft-vs-host
disease, which was followed in 2008 by
a study on our pediatric experience with
PROSE,” Dr. Jacobs notes.
Association Fall Educational Symposium
meeting,” says Dr. Jacobs, adding that his
abstract received second prize. His report
also was selected by the American
Academy of Ophthalmology for presentation
at its annual meeting in October 2014.
Research may lead to expanded use
of PROSE devices
The number of peer-reviewed scientific
publications on PROSE treatment continues
to rise, thanks to the efforts of investigators
within BFS’s BostonSight® Network. “This
is a strong trend at several of the network
sites, where our colleagues have published
some outstanding papers,” says Dr. Jacobs.
“Their independent research validates
what we do at BFS and further increases
awareness of PROSE treatment.”
The first network paper appeared in 2010,
when colleagues at Alkek Eye Center,
Baylor College of Medicine, published a
paper on PROSE treatment for patients
with neurotrophic keratitis due to shingles.
“By 2010, the first truly prospective
Since then, numerous other reports have
study—one that followed a group of
emerged, including from investigators
patients over time—was published. This
at Brooke Army Medical Center in San
project, conducted in collaboration with
Antonio, Texas; at the USC Eye Institute in
the Schneider Institutes for Health Policy at Los Angeles, California; and at Sankara
Brandeis University, measured the impact
Nethralaya and L.V. Prasad Institute, both
of PROSE treatment on patients and
in India.
established its cost-effectiveness.”
In 2014, clinicians at the Kellogg Eye
More recently, Dr. Jacobs has worked
Center in Ann Arbor, Michigan, published
with Joshua Agranat, a student at Boston
a particularly impressive paper, says
University School of Medicine who has an Dr. Jacobs. “Their research showed that
interest in ophthalmology, on a study of the PROSE treatment compares favorably, in
five-year impact of PROSE treatment, which terms of outcomes and risks, to corneal
shows that it offers continued benefit as
transplantation,” she explains. “Also, in
defined by improved visual function in
approximately 26 percent of cases where
patients with complex corneal disease.
commercial scleral lenses were
“Josh’s work was selected for presentation unsuccessful, PROSE treatment was
at the 2013 Cornea Society/Eye Bank
proven to work.”
PAGE 10
At the University of Rochester’s Flaum Eye
Institute, which joined the BostonSight®
PROSE Network in December (see page 6),
research on improving vision with PROSE
treatment continues in the lab of Geunyoung Yoon, PhD. Dr. Yoon has developed
innovative ways to measure higher order
aberrations (HOA), vision problems beyond
nearsightedness, farsightedness or
astigmatism that occur in many
patients with keratoconus and can be
challenging to correct. Before Flaum
was part of the network, Dr. Yoon and a
post-doctoral fellow came to BFS to explore
the feasibility of making optical adjustments
in PROSE devices to improve vision in this
patient population.
“PROSE devices can correct HOAs, which
interfere with finer vision,” explains Dr.
Jacobs. “Some keratoconus patients can’t
be fully corrected with ordinary contact
lenses despite a clear cornea, and PROSE
devices have great potential. Our colleagues
at Flaum, led by Dr. Yoon, are helping push
this boundary by extending this collaborative
work dating back more than five years. Like
him, we want keratoconus patients to get to
20/20 vision.“
Now that Tara Vaz, OD, is providing PROSE
treatment at Flaum, Dr. Yoon has the
on-site support he needs to customize
devices for his research. Moreover,
patients can now be treated and monitored
at Flaum.
Elsewhere at Flaum, James Aquavella, MD,
a cornea specialist, has a longstanding
research interest in the ocular surface and
sees potential for PROSE devices for
patients who have an artificial cornea,
called a keratoprosthesis. “In some of
Funding Goal #5:
Developing Key
Treatment
Innovations
through Clinical
Research
these patients, the surface of the eye is
vulnerable, and their visual acuity is poor,”
says Dr. Aquavella. “We are considering
studying the use of PROSE devices on top
of the artificial cornea to protect the eye.”
of the eye beneath the eyelids. However,
scanning the eye is a challenge, because
the eye is in constant motion, and some of
our more complex patients have difficulty
even opening their eyes.”
Deborah S. Jacobs, MD, medical director,
Progress continues on image-guided
customization
The hope is that more accurate scanning
data will result in a better starting point for
customization of PROSE devices, ultimately
requiring less time, fewer cuts in the lab
and less cost to both the patient and BFS.
As part of the upcoming clinical trial, which
is scheduled to begin in mid-2015, several
PROSE patients will be scanned with one
of these instruments to determine how
image-guided PROSE devices compare
to those produced through the traditional
customization method.
“We continue to innovate at Boston
Foundation for Sight,” says Dr. Jacobs.
“There is no question that philanthropic
support directed to research helps us.
For example, the important Brandeis
collaboration, which established the
clinical and cost-effectiveness of PROSE
treatment, was supported by a donation.
The quest to shorten the current, iterative
process of customizing PROSE devices
through the use of ocular imaging is
well underway. The goal of this research,
now overseen by Chirag Patel, OD, is to
simplify the customization process using
optical coherence technology (OCT) or
laser scanners to generate a 3D image
of the eye. These imaging tools are
being developed with grant support
from the Small Business Innovation
Research program.
“Two companies currently are working on
the instruments,” says Dr. Patel, who joined
BFS in 2014. “Obtaining a comprehensive
image requires stitching multiple scans
together, and we need to scan portions
“If successful, the goal would then be to
make this technology available for use
during the customization of new PROSE
devices in Needham and throughout our
network,” notes Dr. Patel.
PAGE 11
and Chirag Patel, OD, discuss data related
to the image-guided customization research
underway at BFS.
“Making a gift that supports research is
another way to ensure the future—and the
growth—of this important technology,”
she adds. “It may take a few years to
see the results, but fertilizing our research
will bear fruit that ultimately will benefit
many people.”
BFS Strives to Provide Treatment to All Who Need It
Boston Foundation for Sight (BFS) is a 501(c)(3) nonprofit eye healthcare organization. Our Needham,
Massachusetts, Center of Excellence includes a medical institute, a research center, a state-of-the-art
manufacturing lab and a Patient and Family Support Center. As demonstrated by the income statement
below, the majority of our income is generated from insurance and patient payments.
As a nonprofit, BFS actively solicits gifts and grants to support and develop the foundation and fulfill its
mission. We are committed to providing financial assistance to patients so that their lives are no longer lost
to constant eye pain or limited by poor visual function.
In 2014, BFS provided more than $730,000 in financial assistance to patients in Needham and within the
domestic BostonSight® Provider Network. However, the aid required by our patients outstripped
philanthropic gifts, which were lower than in other years. By deepening their commitment, donors will
help BFS continue to provide PROSE treatment to all who need it.
2014 INCOME
AND EXPENSES
INCOME:
Needham clinic revenue, net*
Network provider clinic revenue, net*
Contributions
Rental
Other
Total income
December 31, 2014
December 31, 2013
$
3,105,238
2,136,430
509,578
300,000
73,786
6,125,032
$
$
$
4,269,403
1,260,310
302,753
431,049
6,263,515
$
(138,483)
$
EXPENSES:
Program services
Management and general
Rental
Fundraising
Total expenses
$
Net income (loss)
$
3,467,850
2,304,900
686,700
300,000
163,429
6,922,879
$
4,091,546
1,507,816
304,474
421,883
6,325,719
$
597,160
*Net of financial assistance totaling $731,610 and $719,927 in 2014 and 2013 respectively
The information above has been extracted from the IRS form 990 and the financial statements of Boston Foundation for Sight for
the years ended December 31, 2014 and 2013 that were audited by the independent certified public accounting firm, Mayer
Hoffman McCann, PC, Boston, Massachusetts. A complete set of audited financial statements is available upon request.
PAGE 12
2014 BALANCE SHEET
December 31,
2014
Assets
Current assets:
Cash and cash equivalents
Accounts receivable — patients, net of reserve for
doubtful accounts of $248,000 and $288,000
in 2014 and 2013, respectively
Accounts receivable — network clinics
Other receivables
Prepaid expenses
$
Total current assets
Other assets:
Restricted cash
Deposits
Total other assets
Property and equipment, net
Total assets
3,056,784
2013
$
2,439,602
1,001,556
535,750
67,238
80,027
1,161,100
755,200
123,821
56,920
4,741,355
4,536,643
185,012
32,918
185,361
32,918
217,930
218,279
291,878
435,498
$
5,251,163
$
5,190,420
$
1,012,616
$
813,390
Liabilities and Net Assets
Current liabilities:
Accounts payable and accrued expenses
Total current liabilities
1,012,616
813,390
Total liabilities
1,012,616
813,390
Net assets:
Unrestricted net assets
Temporarily restricted net assets
Permanently restricted net assets
4,029,799
23,748
185,000
4,151,186
40,844
185,000
Total net assets
4,238,547
4,377,030
Total liabilities and net assets
$
PAGE 13
5,251,163
$
5,190,420
Thank You to Our Valued Donors
The following lists recognize donors whose gifts were received between January 1 through December 31, 2014.
Lifetime Giving
Visionary Circle of Hope
$1,000,000 and above
$25,000 and above
Bruce and Holly Johnstone
Michael and Myra McCoy
Kate and Seymour Weingarten
Bausch + Lomb
$250,000 - $999,999
Lorne Abony
Nehemias Gorin Foundation and
Gorin Family Endowment
Michael and Myra McCoy
The Thomas Anthony Pappas
Charitable Foundation
The Samuel Rapaporte, Jr. Foundation
Kate and Seymour Weingarten
$100,000 - $249,999
Frank and Diana Berry
Harry and Honey Birkenruth
Henry and Diane Bisgaier
Blue Cross Blue Shield of Massachusetts
Foundation
The Charles Evans Foundation
Bruce and Holly Johnstone
Florence Koplow
Avinash and Anuja Lele
Marino Charitable Foundation
Michael L. Nash and Carolyn Duffy
Robert and Ruth Remis
Robert and Beatrice Schaeberle
Michael and Helen Schaffer Foundation
The Abraham Shapiro Charity Fund
Enid Starr, Esq.*
Diane Tonna and George Tonna
$50,000 - $99,999
Warren Alpert Foundation
Evelyne Balboni
Theodore W. and Evelyn G. Berenson
Charitable Foundation
Irena Bronstein and Eugene Bonte
Charitable Foundation
Bresky Foundation
Comenitz Family Foundation
LeRoy and Jane Crosby
Sumner and Esther Feldberg
Gerald Flaxer Charitable Foundation
Howard Gorin
John and Olga Guttag
Ann Hintlian
Max and Selma Kupferberg
Family Foundation
Paul T. LaRocca
Michael and Donna Moskow
Larry and Audrey Plotkin
Howard Stoner and Dr. Carol Stoner
Alan and Ann Strassman
Paul Szczygiel
*Deceased
$1,000 - $4,999
Pamela J. Anderson
The Aronson Foundation
Lisa and Jay Berlin
Marvin Berman and Ronna Finer-Berman
Robert W. Best and Elizabeth Wanner
$10,000 - $24,999
Thomas and May Chin
Anonymous
Charles Churchill
The Barbara Epstein Foundation
Merrill and Trudy Cohen
Frank and Diana Berry
Dennis and Jillian Corkum
Harry and Honey Birkenruth
Gertrude Crittenden
Henry and Diane Bisgaier
LeRoy and Jane Crosby
Irena Bronstein and Eugene Bonte
Sandra DeFrancisco
Charitable Foundation
Sumner and Esther Feldberg
Cognex Corporation
Gary and Susan Fentin
Florence Koplow
Esther Freeman
Jane and Jerry Gnazzo
D. Catherine Fuchs, MD
Gerald Flaxer Charitable Foundation
$5,000 - $9,999
Maureen Gillespie
Edward and Nancy Eskandarian
Karen L. Grossman
Allan and Anne Greenberg
Judith Gurewich
Joseph Martini
Rabbi Donniel and Adina Hartman
Max & Selma Kupferberg Family
Elise C. Hauenstein and Norm Abram
Foundation
Jon and Janice Inwood
Michael L. Nash and Carolyn Duffy
Michael Raizman, MD and Debra Raizman Douglas and Edythe Jablonsky
Deborah S. Jacobs, MD and Peter Sacks
Ronald Rock
Joseph B. and Esther L. Grossman
Charitable Foundation
Michael Kane
David Katz
Jay T. Kelly
Gary and Sandra Knaak
Avinash and Anuja Lele
Shaun and Kathleen Levesque
Visionary Circle of Hope donors
Michael Link, MD and Vicki Link
Peter and Tina Locke
make gifts of $1,000 or more
Roger M. Marino
within the calendar year. Their
Barbara J. McNeil, MD
Anna and Mark* Mergen, MD
generosity makes a tremendous
Richard Michaud
difference in the quality of life of
Helaine Miller
Roger and Roberta Neal
our patients and their families. The
Donna Newmyer
important support from these
William H. O’Neill
leadership donors helps us to
Ruth Orenstein
Charles E. Rehn, MD
restore our patients’ sight, which in
Richard and Deborah Sasson
turn helps them regain their lives.
Delia Bowman Sattin
Clifford Scott, OD and Mary Scott, OD
Paul and Josephine Sears
Linda and Richard Smith
Specialty Insurance Managers, Inc.
Edward A. Tanzman
Alice Trisdorfer, PhD
Miriam E. Vincent, MD
Robert K. Walter
Scott and Jacqueline Wellman
PAGE 14
Joseph and Susan Zienowicz
Visionary
Circle of Hope
BostonSight Donors
$500 - $999
Anonymous (2)
Todd Birkenruth
Cail Family Foundation
J. Stephen and Linda E. Collins
Jean and John Conners
Cressey Sports Performance LLC
Timothy Fazio
Richard Grigalunas
Sherri Hendricks
Beverly and Philip Johnston
Ronald J. and Kristine K. Kann
Donald Korb, OD and Joan Korb, OD
Janice R. Lane
Nancy and Maurice Lazarus Fund
John Maisch
The Max & Elizabeth Blume Silverstein
Foundation
Mary McCune
David and Dora Middleton
Eleanore Moran
Jerry Mulder
David and Patricia Nestler
Carmen Paradis and Brian McGrath
Michael E. and Marti Partridge
John and Sharon Poole
William Pospisil
Brent and Caroline Stone
Carl Valvo and Mav Pardee
Dorothy Waldron
Steven and Sharon Weber
Daniel and Rosemary Wywoda
Zeitz Foundation Trust
$250 - $499
Abul Abbas, MD and Ann Abbas, MD
Kimberly Berry
Carroll and Raymond C. Charette
Angela Churchill
John F. Cogan, Jr.
Mary and Deborah Cormier
Anna Cressey, OD and Eric Cressey
The David Gopen Foundation
Joe and Maureen Fazio
John E. Fitzgerald
Peter. W. FitzRandolph, MD
Betty Lou Gallardo
C.R. Grigg
Heidi Joy Hodges
Heidi Price Design
Theodore and Ruth-Arlene Howe
Charles and Joan Killilea
Ilene Knopping and Cliff Kolovson
Sharon and Howard Levitan
Honorable Stephen M. Limon
Mark Maciolek
Margaret Mansfield
Mark Martini and Family
P. Mark Martini
Bob and Donna Metafora
Chris Moyroud
John Mulder
Joan E. Murphy
Louis Pulzetti
The Remis Trust Fund
William Rodgers
Robert and Susan Seyler
Charles and Eileen Share
Mr. and Mrs. Robert Strom
Charles and Susan Tate
Arnold Wallenstein
Joseph and Erika Wannemacher
Jerome and Joan Weinstein
William Wright, MD and Joanna Wright
Eileen and Craig Yarnell
Under $250
Anonymous (25)
Ruth Abelmann
Lawrence M. and Linda M. Abramson
Rao Addanki
Lamia Adjout
Martha Akagi
Virginia C. Alden
Barbara Amato
AmazonSmile Foundation
Seymour Andrus
Richard Apalakian
Steven M. Appel
William and Andrea Arcuri
Mark and Suzanne Aucoin
Norman and Monique Avey
Robert Awkward
Zella Axelrod
Bonnie Bader
Jim and Patricia Bailey
Ross Baldessarini
David Baltisberger
Janet Barker
Kenneth Barnes
Paul and Joetta Barnett
Stephen Barry
Michael Baxter
Douglas W. Bell, MD
Michael and Helen Bellas
Kathleen Bellew
Karyn Benson
Iris Berent
Joanne Berger
Daniel Berlin
Joan Feinberg Berns
Scott and Katherine Berrier
Alexandra Berwick
Paul C. Bettinger
Ann Bixel
Richard Blacher, MD
Evelyn Blanchard
Jaxon Bobbitt
Lindsay Bock
PAGE 15
Mary Flair Bogan
Raymond Boghos
Alan R. Boling
Ethan Bolker
Kathleen and James Bond
Constance Bonner
Kathleen K. Bowen
Robert K. Bower
Nancy Bowers
Donald and JoAnn Bowman
Sally Sparks Boyd
Nora Boyle
Susan Brady
Bill and Helen Bragdon
Jack and Nancy Brennan
Peter and Evelyn Brewster
Robert and Marie Britt
Francis and Linda Brockway
Norbert P. Brouchoud
Maurice and Karen Brown
Jeanne Bruno
Kathryn R. Buckheit
Leslie A. Burg
Karen Burgess
Ian Burke
Peter Burness
Timothy Burnett
Joseph Burris
Ms. Nancy Naylor Busby
John and Debbie Butz
The Cacela Family
Gerald Cadran
Cherilyn Caga-Anan
Faye Calhoun
Betty and Joe Caplan
Joanne Caputo
Sharlene Carter
Steven and Kathleen Case
Marvin and Edith Catler
Thomas and Jean Catlin
Veronica Cavaco
John and Ellen Cavaiuolo
Anthony J. Cavanna
Larry and Ann Chait
Brandy Chambers
Arthur and Carole Chen
Diane Cimilluca
Dorothy Ciriani
Karen Clift
Joan Cody-Wingo
Jeffrey Cohen
Richard Cohen
Carole and Dom Colannino
Richard and Julie Colon
Molly Compton
Lee Connors
Nancy Cook
Susan R. Costello
Donna and Doug Cowan
John and Robin Coyne
Craigs Landscaping Inc.
Robert Crane
John and Holly Cratsley
Ruth Curran
Cynthia Costa Davis
Eric D.
Joanne Dayton
Tom and Valarie DeFelice
John Delude
Robert and Julie Dempsey
Kenneth and Marcia Denberg
William and Deborah Dennett
Jean A. Desmond
Nancy DeSouza
Mary Diab
Li Diao and Haixiang Zhu
Carlos Diaz Gonzalez
Amy Dibattista
Albert and Elizabeth Dibbins
Sandra Dick
Jennifer Dickson
Elinor DiIorio
Renee Domegan
Richard and Joan Donnelly
Michael T. Dorsett
Arthur, Janice and Lynn Drinkwater
John and Lisa Dubczak
Kevin Dugan
William and Lori Dugas
Mary Dunbrack
Lois and Bernie Edinberg
Phyllis Ellis
Patti Englert
Dan Eshet
Rhea T. Eskew, Jr.
Cliff Evans
James and Catherine Fallon
Henry and Kathleen Faulkner
Roslyn Feldberg
Sarah Feldberg
Stephen Feldhoff and
Margaret O’Meara Feldhoff
James R. Felicetti
Deborah Fenn and Stephan Steisel
David Fenton
Victor S. Ferreira
Jacquelin Fiedler
John Finn
Luke F. Finn
Lesley and Mark Finn
Ron and Kathy Fisher
Jamie and Dennis Floyd
Julia Fox
Janice Foye
John Franconere
Vincent Fratello, PhD
Jonathan Friedman
Sanford and Elyse Friedman
Linda and Michael Frieze
Anthony Fucillo
Mary Furlong
Betty Gerathy
Jeffrey Gerson
Edward Gibson
Bob and Joan Gillespie
Karen Gillespie
Sean Gillespie
Arlene Gilman
Tamara Gilman
Karen Ginsberg
Edward Ginsburg
Nancy Glazer Pearl
Jeffrey Gold, MD
Valerie Goldstein
Sheryl Goodridge
Anna S. Green
Gary and Patricia Green
Dottie and Bob Grodberg
Aron Grossman
Clarke and Betty Guilliams
Sarah Gunnery
Evan Haberman
Sterling Hale
Vivian Lee Hamilton
Cathleen Hardisty
James and Helen Harney
Danielle Hartigan
Christopher Hawrylow
Anita L. Hayes
Robert and Janice Hayflick
Jordana R. Heller
Deborah Hirsch
Gloria Hitt
Lillian Ho
David Hobson
John F. Hogan
Marida Hollos
Brad Honoroff
Joan Hoogasian
Ellen Hopkins
Kenneth and Beverly Horn
Michael Horn
Shirley Houghton
Lynne Hourigan
Lynn Hughes
Rose Hurwitz
Barry and Doris Hyman
Jeannette Iles
Elaine Inker
Ruth Isaacs
Wanda Jackson
Christine Jantzen
Jeanne P. Valente
Klavs Jensen
Odell Johnston, Sr. and Carol Johnston
E. Ann and Brian Keith Jones
John J. Joy
Barbara Juell
Carolyn, Alan and Meryl K
Karen Kaliris
Robert Kane
A.W. and Barbara Karchmer
Barbara Karr
Robert and Geraldine Kastner
Joel D. Katz
Leslie S. Kaufman
Patrick Keating
Margaret Kelley
Carol Kent
Dorothea P. Kerle
Nancy Kim
Ken and Melinda Kimball
Howard King, MD and Phyllis King
Suzanne Cook Kinsellagh
Anne M. Kiritsy
Judith Geleerd Kitzes
Andrew Klein
Daniel Kleinman
Gerard J. Klingman
PAGE 16
Elaine Knowlton
Joseph and Dorothy Kosewicz
Joan Krasnoo
Michael J. and Ilana Kraus
Bruce and Ruth Kuhnert
S.M. “Terry” and Rosalie LaCorte
Deborah Lang-Savini
Susan Lanteri
Linda Large
Fred Lawrence
Darrow Lebovici
Keng Jen and Judith M. Lee
John Lescher
Alan Leventhal
Wendy Levey
Barbara Levine
Martin and Sandra Levy
Cindy Lewis
Nancy and Paul Lidard
Walter I. Lipsett
Kenneth Love
Jessica A. Love
Jack and Maria Lynch
Joan Sullivan and Larry Lynch
Patrick E. Lynch
Brenna Maguire
Kathleen Malloy
Phillip and Donna Malyak
Lillian Mamon
Anne Marcus
Nancy and Jean-Pierre Marjollet
Diane Marks
Vivian and Richard Marson
Andrea W. Martin
Matthew and Margarethe Mashikian
Daniel Massarelli, MD and
Sheila Massarelli
Mark and Catherine Mathers
Patricia Matthews
Daniel M. McDonald, Esq.
James McDonnel
Paul McDonough
Richard McGanty
Mary McGillivray
Joan McGuirk
William and Eleanor McGuirk
Carol McHugh
Mary McMahon-Chappel
David A. McMullin
Ralph and Ina Melen
Sherry Widman and Richard Mendelson
Nancy Mercado
Tony Messec
Richard and Joan Metcalfe
Carol T. Meyer and Family
Kalvin and Jan Milan
Sarah Millar
Joanne L. Miller
Alison Moll and Fred Benjamin
Eva Mongeon
Richard and Roberta Moran
Tuuli Morrill
Steven Moskowitz
Craig Mulvaney
Dan and Debra Murray
Josephine Napoli
Scott Nascimento
William and Rita Needel
Nancy Nelson
Carlos Neu, MD and Judith Neu
Gary Newman
Paula Nobili
Willard H. Noble
Merle A. Noll
Mike Novack
Cheryl O’Brien
Mary O’Connor
Carol J. Odman
Alice O’Donoghue
Eli and Bonnie Okrant
Daniel Omara
Miriam L. Ornstein, MD
Robert and Marjorie Ory
Kathy Owen
Eltha Palmer
Mairead Paoli
Edward Parolin
Neal Pearlmutter
Beverly Siegal Peiser and Richard Peiser
Kendell Penney
Cari Pepkin
Thomas and Sharon Perosky
Augusta Petrone
Francis Pettengill
Steven Piantoadosi
John Picerne
Ellen Pichey, MD
David Pillemer
Tamela Hoover Pink
Frank J. Pirrotta
William and Sheila Pocaro
Susan Polivy
Carmen Puopolo
Jason Puzniak
Linda Racine
Raymond and Geraldine Radzanowski
Richard Raiselis
Lyndsey M. Rawson
Orlyn Reese
Cintra Reeve
Lorraine Regan
Susan Regan
Teri Piatt
Linda Reichert
Michael Reinhorn, MD and
Stefanie Reinhorn
Sherry Reisner
David and Chelsey Remington
James Reynolds
Richard Reynolds
Anita Rice
Roberta Richards
Elizabeth Riordan
Charles Robbins
Cesar Rodriguez
Thomas and Mary Rogers
Ilana Roman
Tereso Saucedo and Luz Rosales-Lopez
Beverly Rosen
Karen Rosen
Paula Rosen
Sylvia Rosenblatt
Cynthia Rosenstein and Marty Yespa
Patricia and Leonard Rosenthal
Julie Ross
Barbara Rostosky
Jacqueline Royce, MD
T. Michael and Angela C. Russo
Carlos Sa
Florence Sacco
Howard R. Sacks
George Sahas
Shahzad Saleem
Andrew Salk
Willem Maarten Samsom
M. Santiago, Jr.
Brenda Hernandez Santiago, MD
Tedd and Ella Saunders
Judy Saxe
Joseph F. Scancarella
Casey Scavone
Robin L. Scholefield
Sylvia Scholnick
Mari Hirsh and James Schreiber
Joanne Sears
Marvin Segal
Beth and Michael Sellman
Joseph Sergi
Sandra Shapiro
Neil Shernoff
Gene Sherron, PhD
Christopher and Linda Shumate
Stephen Shusterman
Stephen Silk
Alfred and Roslyn Silverman
Michelle Silvia
Karen Simat
Devra Simon
Margaret Simon
Shobha and Kamlesh Singh
Paul and Terri W. Skiver
Spencer Sleeper
Ellen R. Smith
Kent Smith
Quinn Smith
Neal and Sierra Snider
Marc Snyder
Benjamin and Thelma Soble
Dorothy Solomon
Laurie Sparks
Rosalind Spigel
Karen Spikes
Stanhope Garage, Inc.
Marjorie Stanzler
Joe Michalak and Judy Steen
Merrill Stein
Dorothy Steinbach
Donald Steinbrecher
Howard Stoner and Carol Stoner, MD
Mark F. Straffin
David and Lorna Strassler
Alan and Ann Strassman
Andrew Strauss
Ann Strominger
Patricia and Dennis Strusa
Anna R. Sullivan
James and Ruth Sullivan
Joan P. Szczepkowski
Nancy Tepper
James and Carol Ann Thomas
Patricia Thomas
Irwin Thompson, MD
Winston C. Thompson
Harry Tily
David and Karen Ting
Myrna Titelbaum
Louis and Barbara Tobasky
Herbert Tobin
Molly Tobin
Sharee K. Tolbert
Robert C. Tommasino
Jian Tong-Clark
Jan Tornick
Thomas Toronto
David Torres
Willard Traub
Sotirios Tsimikas, MD and Athena Tsimikas
Richard L. Tuck
Nelson and Lynn Tucker
Samantha Tye
Ted Tye
Sheri M. Uliano
UMassMemorial Medical Center Care
Coordination Dept.
Eric and Laurie Van Loon
Julie Vanek
Marcos Vargas
Elizabeth Varley-Horan
Victoria Vaserman
Angela Veloz
Jean M. Vnenchak
Jeanne and Jim Walker
The Walsh Family
Judith Warnement
Ellen Wassarman
Kenneth and Femi Wasserman
Brian Wasserstein
Anne Weatherwax
Herbert and Eleanore Weiss
Irwin Weiss
Monika Wellenstein
Victoria Whalen
Anthony Whittemore, MD
John Wilkins
James and Melissa Willis
John and Sheila Wilson
Richard and Frances Winneg
Andrew Wolff
Andy Wong
Robert Woodbury
Loreen Afua Wutoh
Justin Wyner
Marcia Yanofsky
Judy Dunn and Stephanie Yonowitz
Clement Zielinski
GIFTS IN KIND
Bausch + Lomb
MATCHING GIFTS
Bank of America
BNY Mellon
Cargill
Chevron Corporation
CNA Foundation
Johnson & Johnson
Liberty Mutual Foundation
Qualcomm
Every effort has been made to ensure the accuracy of
our donor listings. If there is a misspelling, omission or
improper listing, please accept our sincere apologies and
call 781-726-7512 so that we may correct our records.
Boston Foundation for Sight
Board of Directors
Senior Staff
Staff
Gary A. Knaak
Chairman
Eugene A. Bonte, MBA
President and CEO
Pamela J. Anderson
Mark Ealey
Gary S. Fentin, Esq.
Andrew Hirsch, MBA
Beverly R. Johnston
Michael Kane, MBA
Barbara Joyce McNeil, MD, PhD
Michael B. Raizman, MD
Clifford Scott, OD, MPH
Kate Weingarten, MBA, CFA, MPA
Eugene A. Bonte, MBA
President and CEO
Carmen R. Addario, MPAH
Chief Operating Officer
Manoel Carvalho
Lab Manager
Steve Corlett
Director of Lab Operations
Melinda Kimball
Human Resources and Payroll Manager
Ilene Knopping
Director of the BostonSight® Network
Olga Tomashevskaya
Director of Engineering
Sara Yost, MBA
Director of Finance and Administration
Pedro Araujo
Alana Baker
Artur Barbosa
Ashley Brito
Susan Carlyle
Lynn Carter
Samantha Cohen
Rita DeFlaminis
Yurly Fershter
Kyle Fonseca
Gillian Fontana
Elizabeth Gibson
Daniel Gosselin
Yudit Guzman
Melissa Hatch
Sheila Kelly
Bill King
Nancy Lemist
David Loomis
Pernell McDaniel
Marianne O’Sullivan
Isabell Ofgant
Henryka Paczuska
Kevin Renaud
Darlene Riordan
Robert Smith
Loren Stead
Tara Stepanian
Heidi Wolfe
Medical Staff
Deborah S. Jacobs, MD
Medical Director
Karen G. Carrasquillo, OD, PhD, FAAO
Director, Clinical Care
Rutvi Doshi, OD, FAAO
Alan Kwok, OD, FAAO
Amy Paminder, MD
Chirag Patel, OD, FAAO
Crystal Remington, OD, FAAO
Design: Heidi Price Design
Editorial Services: Laura Duffy
Photography: Tony Rinaldo
Kimberly McKinzie (page 7)
464 Hillside Avenue, Suite 205
Needham, MA 02494
781-726-7337
www.bostonsight.org